This product is a narrow-spectrum antibiotic with actions similar to erythromycin, demonstrating good activity against Gram-positive cocci, particularly high efficacy against anaerobes, Staphylococcus aureus, and Streptococcus pneumoniae. Its mechanism of action is analogous to that of erythromycin, classified as a bacteriostatic agent. It primarily inhibits bacterial cellular protein synthesis. Clinically, it is mainly used for various infections caused by susceptible bacteria, such as pneumonia, meningitis, endocarditis, cellulitis, tonsillitis, erysipelas, furuncles, and urinary tract infections. Due to its ability to penetrate bone tissue and exhibit a special affinity for bone, it is particularly suitable for infections caused by anaerobes and *Staphylococcus aureus*-induced osteomyelitis.

Highly Effective Antibacterial Activity: Exhibits strong inhibitory effects against Gram-positive bacteria (such as staphylococci and streptococci) and some anaerobic bacteria.  

Well-Defined Mechanism of Action: Exerts antibacterial effects by inhibiting bacterial protein synthesis (binding to the 50S ribosomal subunit).  

Good Stability: Stable under dry conditions, but aqueous solutions are sensitive to light and heat, requiring light-protected storage.  

Good Solubility: Easily soluble in water, suitable for preparing various dosage forms such as injections and tablets. 

Wide Application: Used for the treatment of respiratory tract infections, skin infections, osteomyelitis, etc.